NXGL NEXGEL, INC.

$0.34 -4.09%

Updated 16 d ago

Healthcare · Surgical & Medical Instruments & Apparatus

NEXGEL, INC. (NXGL) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $3 million. Shares last traded at $0.34, 88.0% below their 52-week high. Over the past year the stock is down 85.7%. Net profit margin is -51.3%, below the peer median of -9.3%. Revenue grew 31.5% year over year.

Market Cap

$3M

Shares Out

9.7M

EPS (TTM)

$-1.09

P/E Ratio

—

P/S Ratio

0.27

P/B Ratio

0.67

Dividend / Share

—

Dividend Yield

—

52-Week High

$2.84

52-Week Low

$0.29

Volume

300

Avg Vol (3m)

10,892.667

Performance

-6.91%

-19.14%

-44.93%

-71.69%

YTD

-81.23%

-85.67%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

43.23

SMA (50)

$0.45

SMA (200)

$0.99

Price vs SMA50

-24.98%

Price vs SMA200

-65.61%

ATR (14)

$0.05

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue

$12M

Net Income

$-6M

Gross Margin

35.1%

Operating Margin

-44.8%

Net Margin

-51.3%

Return on Equity

-125.0%

Return on Assets

-23.4%

Current Ratio

0.43

Debt / Equity

0.11

Revenue Growth (YoY)

+31.5%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

Period	EPS (diluted)	Reported
Q2 2026	$-0.54	2026-08-17
Q1 2026	$-0.11	2026-05-14
FY 2025	$-0.38	2026-03-31
Q3 2025	$-0.26	2025-11-12
Q2 2026	$-0.18	2026-08-17
Q1 2026	$-0.09	2026-05-14

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

NXGL vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap. Updated 16 d ago

P/S vs peers

0.27 / 2.94 med

-91% discount

Net margin vs peers

-51.3% / -9.3% med

below median

1–14 of 14


SYK	Stryker Corporation	$118.2B	31.69	4.57	14.4%	-1.31%
MMM	3M	$86.8B	28.97	3.45	11.9%	-0.28%
BSX	Boston Scientific	$68.0B	18.54	3.24	17.5%	-3.17%
BDX	Becton Dickinson	$51.1B	54.30	2.45	4.5%	+0.00%
DXCM	DexCom	$33.9B	33.86	6.81	20.1%	+0.02%
RMD	ResMed	$33.1B	21.70	5.85	26.9%	-0.78%
MDLN	Medline Inc.	$30.7B	—	1.08	—	+0.88%
WST	West Pharmaceutical Services	$24.1B	42.67	7.25	17.0%	+0.00%
SOLV	Solventum	$15.7B	10.97	1.89	17.3%	+0.56%
BAX	Baxter International	$13.2B	-12.44	1.15	-9.3%	-0.51%
PEN	Penumbra Inc	$12.7B	78.81	9.02	11.4%	-0.46%
GKOS	Glaukos Corp	$10.6B	-56.59	17.36	-30.7%	+0.52%
GMED	Globus Medical Inc	$10.5B	19.59	3.34	17.0%	-3.14%
PODD	Insulet Corporation	$10.4B	27.82	3.42	12.3%	+1.63%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.